Justin Watson

Justin Watson

Ask VT AI

View News Summary

Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
AI reshapes cities, work, and inequality, with both benefits and concerns around fairness and social harms.
Cowboys make trade ahead of NFL deadline, Jones says, as team looks to address defensive issues

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
AI reshapes cities, work, and inequality, with both benefits and concerns around fairness and social harms.
Cowboys make trade ahead of NFL deadline, Jones says, as team looks to address defensive issues

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Justin Watson